293 related articles for article (PubMed ID: 19090982)
1. Small molecule activators of the Trk receptors for neuroprotection.
Webster NJ; Pirrung MC
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S1. PubMed ID: 19090982
[TBL] [Abstract][Full Text] [Related]
2. Small molecule neurotrophin receptor ligands: novel strategies for targeting Alzheimer's disease mechanisms.
Longo FM; Yang T; Knowles JK; Xie Y; Moore LA; Massa SM
Curr Alzheimer Res; 2007 Dec; 4(5):503-6. PubMed ID: 18220511
[TBL] [Abstract][Full Text] [Related]
3. Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease.
Kwakowsky A; Milne MR; Waldvogel HJ; Faull RL
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999310
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophin receptor-based strategies for Alzheimer's disease.
Longo FM; Massa SM
Curr Alzheimer Res; 2005 Apr; 2(2):167-9. PubMed ID: 15974914
[TBL] [Abstract][Full Text] [Related]
5. Development of Precision Small-Molecule Proneurotrophic Therapies for Neurodegenerative Diseases.
Janssens J; Lu D; Ni B; Chadwick W; Siddiqui S; Azmi A; Etienne H; Jushaj A; van Gastel J; Martin B; Maudsley S
Vitam Horm; 2017; 104():263-311. PubMed ID: 28215298
[TBL] [Abstract][Full Text] [Related]
6. Neurotrophin-based strategies for neuroprotection.
Longo FM; Massa SM
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S13-7. PubMed ID: 15665408
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats.
Högyes E; Nyakas C; Kiliaan A; Farkas T; Penke B; Luiten PG
Neuroscience; 2003; 119(4):999-1012. PubMed ID: 12831859
[TBL] [Abstract][Full Text] [Related]
8. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease.
Salehi A; Verhaagen J; Dijkhuizen PA; Swaab DF
Neuroscience; 1996 Nov; 75(2):373-87. PubMed ID: 8931004
[TBL] [Abstract][Full Text] [Related]
9. BDNF up-regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia.
Ferrer I; Ballabriga J; Martí E; Pérez E; Alberch J; Arenas E
Brain Pathol; 1998 Apr; 8(2):253-61. PubMed ID: 9546284
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophin receptors and selective loss of cholinergic neurons in Alzheimer disease.
Boissière F; Lehéricy S; Strada O; Agid Y; Hirsch EC
Mol Chem Neuropathol; 1996; 28(1-3):219-23. PubMed ID: 8871962
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of neurotrophin receptors and ligands in vertebrate neurons: tools for evolutionary stability or changes in neural circuits?
von Bartheld CS; Fritzsch B
Brain Behav Evol; 2006; 68(3):157-72. PubMed ID: 16912469
[TBL] [Abstract][Full Text] [Related]
12. The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.
Ren K; King MA; Liu J; Siemann J; Altman M; Meyers C; Hughes JA; Meyer EM
Neuroscience; 2007 Aug; 148(1):230-7. PubMed ID: 17640819
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's therapeutics: neurotrophin small molecule mimetics.
Massa SM; Xie Y; Longo FM
J Mol Neurosci; 2002; 19(1-2):107-11. PubMed ID: 12212765
[TBL] [Abstract][Full Text] [Related]
14. Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.
Hölscher C
Rev Neurosci; 2005; 16(3):181-212. PubMed ID: 16323560
[TBL] [Abstract][Full Text] [Related]
15. The cell cycle molecules behind neurodegeneration in Alzheimer's disease: perspectives for drug development.
Copani A; Guccione S; Giurato L; Caraci F; Calafiore M; Sortino MA; Nicoletti F
Curr Med Chem; 2008; 15(24):2420-32. PubMed ID: 18855671
[TBL] [Abstract][Full Text] [Related]
16. Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease.
Boissière F; Hunot S; Faucheux B; Hersh LB; Agid Y; Hirsch EC
Dement Geriatr Cogn Disord; 1997; 8(1):1-8. PubMed ID: 8997546
[TBL] [Abstract][Full Text] [Related]
17. Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease--a target for neuroprotective treatment strategies?
Münch G; Deuther-Conrad W; Gasic-Milenkovic J
J Neural Transm Suppl; 2002; (62):303-7. PubMed ID: 12456073
[TBL] [Abstract][Full Text] [Related]
18. A small molecule TrkB/TrkC neurotrophin receptor co-activator with distinctive effects on neuronal survival and process outgrowth.
Yang T; Massa SM; Tran KC; Simmons DA; Rajadas J; Zeng AY; Jang T; Carsanaro S; Longo FM
Neuropharmacology; 2016 Nov; 110(Pt A):343-361. PubMed ID: 27334657
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophic factors in Alzheimer's disease: role of axonal transport.
Schindowski K; Belarbi K; Buée L
Genes Brain Behav; 2008 Feb; 7 Suppl 1(1):43-56. PubMed ID: 18184369
[TBL] [Abstract][Full Text] [Related]
20. Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's.
Wyss-Coray T
Curr Alzheimer Res; 2006 Jul; 3(3):191-5. PubMed ID: 16842094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
